Population pharmacokinetics and limited sampling strategies of polymyxin B in critically ill patients.

Objectives: To characterize the pharmacokinetics (PK) of polymyxin B in Chinese critically ill patients. The factors significantly affecting PK parameters are identified, and a limited sampling strategy for therapeutic drug monitoring of polymyxin B is explored.

Methods: Thirty patients (212 samples) were included in a population PK analysis.